Editas Medicine, Inc. (EDIT)
NASDAQ·Healthcare·Biotechnology
$2.61
-0.57%
Mkt Cap $254.54M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (20 analysts)
$5.00
Range $4.00 – $6.00
Implied Upside
+91.9%
Consensus $5.00 vs current $2.61
NASDAQ·Healthcare·Biotechnology
$2.61
-0.57%
Mkt Cap $254.54M
Buy
3
Hold
0
Sell
0
Price Target (20 analysts)
$5.00
Range $4.00 – $6.00
+91.9%
Consensus $5.00 vs current $2.61